• TRADE NAMES: Avage (Allergan); Fabior (GSK); Suretin; Tazorac (Allergan); Zorac (Allergan)
  • INDICATIONS: Acne vulgaris, mild to moderate plaque psoriasis involving up to 10% body surface area
  • HALF-LIFE: 18 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric